Keryx Biopharmaceuticals, Inc. Overview
Company Headquarters: Massachusetts, US
Founded: 1997
Workforce: 200
Company Working:
Keryx Biopharmaceuticals, Inc. (Keryx) is the wholly owned subsidiary of Akebia Therapeutics. The merged company functions under the name of Akebia. It is into developing and delivering therapies to patients suffering from chronic kidney disease.
Strategy
Keryx focuses on engaging in mergers and acquisitions to expand in the market. It also focuses on acquiring or in-licensing other nephrology products.



